Sandoz Group AG Logo

Sandoz Group AG

SDZ.SW

(0.5)
Stock Price

40,17 CHF

0.04% ROA

0.05% ROE

3921.9x PER

Market Cap.

17.896.161.296,00 CHF

52.47% DER

1.26% Yield

0.05% NPM

Sandoz Group AG Stock Analysis

Sandoz Group AG Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Sandoz Group AG Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (0%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 ROE

Negative ROE (-29.64%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

3 ROA

The stock's ROA (-22.86%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

4 PBV

The stock's high Price-to-Book Value (P/BV) ratio (142700.06x) suggests it's overvalued, potentially making it an expensive investment.

5 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

6 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

7 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

8 Graham Number

The company's Graham number suggests that its stock price is overestimated, implying that it may not be a promising investment opportunity.

9 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (0), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

Sandoz Group AG Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Sandoz Group AG Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Sandoz Group AG Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Sandoz Group AG Revenue
Year Revenue Growth
2020 8.550.323.979
2021 8.829.239.400 3.16%
2022 8.604.234.540 -2.62%
2023 8.393.137.320 -2.52%
2024 10.124.000.000 17.1%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Sandoz Group AG Research and Development Expenses
Year Research and Development Expenses Growth
2020 772.875.630
2021 831.105.300 7.01%
2022 45.304.910 -1734.47%
2023 34.484.280 -31.38%
2024 978.000.000 96.47%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Sandoz Group AG General and Administrative Expenses
Year General and Administrative Expenses Growth
2020 0
2021 0 0%
2022 22.500 100%
2023 -379.659.880 100.01%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Sandoz Group AG EBITDA
Year EBITDA Growth
2020 1.283.699.500
2021 1.678.632.000 23.53%
2022 1.534.819.400 -9.37%
2023 667.817.520 -129.83%
2024 1.082.000.000 38.28%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Sandoz Group AG Gross Profit
Year Gross Profit Growth
2020 3.947.597.289
2021 4.195.667.700 5.91%
2022 4.047.855.020 -3.65%
2023 3.838.689.120 -5.45%
2024 4.760.000.000 19.36%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Sandoz Group AG Net Profit
Year Net Profit Growth
2020 409.013.220
2021 828.368.400 50.62%
2022 784.052.320 -5.65%
2023 77.000.000 -918.25%
2024 300.000.000 74.33%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Sandoz Group AG Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2020 1
2021 2 100%
2022 2 0%
2023 0 0%
2024 1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Sandoz Group AG Free Cashflow
Year Free Cashflow Growth
2020 720.855.475
2021 855.753.359 15.76%
2022 760.231.833 -12.56%
2023 -242.635.973 413.32%
2024 32.000.000 858.24%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Sandoz Group AG Operating Cashflow
Year Operating Cashflow Growth
2020 1.030.598.061
2021 1.237.916.718 16.75%
2022 1.168.044.637 -5.98%
2023 325.311.933 -259.05%
2024 114.500.000 -184.12%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Sandoz Group AG Capital Expenditure
Year Capital Expenditure Growth
2020 309.742.586
2021 382.163.359 18.95%
2022 407.812.804 6.29%
2023 567.947.906 28.2%
2024 82.500.000 -588.42%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Sandoz Group AG Equity
Year Equity Growth
2020 6.826.745.850
2021 7.437.717.450 8.21%
2022 11.179.539 -66429.73%
2023 7.283.639.100 99.85%
2024 8.368.000.000 12.96%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Sandoz Group AG Assets
Year Assets Growth
2020 15.863.366.700
2021 15.983.393.300 0.75%
2022 100.000 -15983293.3%
2023 16.353.259.500 100%
2024 19.319.000.000 15.35%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Sandoz Group AG Liabilities
Year Liabilities Growth
2020 9.036.620.850
2021 8.545.675.850 -5.74%
2022 22.861 -37380923.8%
2023 9.069.620.400 100%
2024 10.951.000.000 17.18%

Sandoz Group AG Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
22.57
Net Income per Share
0.01
Price to Earning Ratio
3921.9x
Price To Sales Ratio
1.84x
POCF Ratio
35.3
PFCF Ratio
135.58
Price to Book Ratio
2.13
EV to Sales
2.22
EV Over EBITDA
34.05
EV to Operating CashFlow
42.66
EV to FreeCashFlow
163.52
Earnings Yield
0
FreeCashFlow Yield
0.01
Market Cap
17,90 Bil.
Enterprise Value
21,59 Bil.
Graham Number
2.15
Graham NetNet
-15.91

Income Statement Metrics

Net Income per Share
0.01
Income Quality
-63.25
ROE
0
Return On Assets
0
Return On Capital Employed
0.02
Net Income per EBT
-0.48
EBT Per Ebit
-0.04
Ebit per Revenue
0.03
Effective Tax Rate
-12.85

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0.09
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
0.45
Operating Profit Margin
0.03
Pretax Profit Margin
-0
Net Profit Margin
0

Dividends

Dividend Yield
0.01
Dividend Yield %
1.26
Payout Ratio
47.2
Dividend Per Share
0.45

Operating Metrics

Operating Cashflow per Share
1.18
Free CashFlow per Share
0.31
Capex to Operating CashFlow
0.74
Capex to Revenue
0.04
Capex to Depreciation
0.82
Return on Invested Capital
0.27
Return on Tangible Assets
0
Days Sales Outstanding
98.53
Days Payables Outstanding
110.52
Days of Inventory on Hand
198.03
Receivables Turnover
3.7
Payables Turnover
3.3
Inventory Turnover
1.84
Capex per Share
0.87

Balance Sheet

Cash per Share
1,63
Book Value per Share
19,45
Tangible Book Value per Share
-1.7
Shareholders Equity per Share
19.45
Interest Debt per Share
10.2
Debt to Equity
0.52
Debt to Assets
0.23
Net Debt to EBITDA
5.82
Current Ratio
1.22
Tangible Asset Value
-0,73 Bil.
Net Current Asset Value
-3,61 Bil.
Invested Capital
12316000000
Working Capital
1,32 Bil.
Intangibles to Total Assets
0.47
Average Receivables
2,62 Bil.
Average Payables
1,61 Bil.
Average Inventory
2883000000
Debt to Market Cap
0.25

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Sandoz Group AG Dividends
Year Dividends Growth
2024 0

Sandoz Group AG Profile

About Sandoz Group AG

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. It develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. The company was founded in 1886 and is headquartered in Rotkreuz, Switzerland.

CEO
Mr. Richard Saynor
Employee
22.633
Address
Suurstoffi 14
Rotkreuz, 6343

Sandoz Group AG Executives & BODs

Sandoz Group AG Executives & BODs
# Name Age
1 Mr. Richard Saynor
Chief Executive Officer
70
2 Mr. Remco J. Steenbergen
Chief Financial Officer
70
3 Mr. Asaf Gal
Chief Technology Officer
70
4 Ms. Claire D'Abreu-Hayling
Chief Scientific Officer
70
5 Ms. Karen M. King
Head Global Investor Relations
70
6 Ms. Ingrid Sollerer
General Counsel & Chief Compliance Officer
70
7 Ms. Tripti Jha
Chief People Officer
70
8 Mr. Francisco Ballester
President of International
70
9 Mr. Pierre Bourdage
Chief Commercial Officer
70
10 Dr. Glenn A. Gerecke Ph.D.
Chief Manufacturing & Supply Officer
70

Sandoz Group AG Competitors